Skip to main content
Top
Published in: Abdominal Radiology 6/2013

01-12-2013

Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)

Authors: Maria Antonietta Mazzei, Leila Khader, Alfredo Cirigliano, Nevada Cioffi Squitieri, Susanna Guerrini, Beatrice Forzoni, Daniele Marrelli, Franco Roviello, Francesco Giuseppe Mazzei, Luca Volterrani

Published in: Abdominal Radiology | Issue 6/2013

Login to get access

Abstract

Purpose

To evaluate the accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent a peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) after neoadjuvant chemotherapy to obtain a pre-surgery prognostic evaluation and a prediction of optimal cytoreduction surgery.

Materials and methods

Pre-HIPEC CT examinations of 43 patients with advanced ovarian cancer after neoadjuvant chemotherapy were analyzed by two radiologists. The PCI was scored according to the Sugarbaker classification, based on lesion size and distribution. The results were compared with macroscopic and histologic data after peritonectomy and HIPEC. To evaluate the accuracy of MDCT to detect and localize peritoneal carcinomatosis, both patient-level and regional-level analyses were conducted. A correlation between PCI CT and histologic values for each patient was searched according to the PCI grading.

Results

Considering the patient-level analysis, CT shows a sensitivity, specificity, PPV, NPV, and an accuracy in detecting the peritoneal carcinomatosis of 100 %, 40 %, 93 % 100 %, and 93 %, respectively. Considering the regional level analysis, a sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 72 %, 80 %, 66 %, 84 %, and 77 %, respectively were obtained for the correlation between CT and histology.

Conclusion

Our results encourage the use of MDCT as the only technique sufficient to select patients with peritoneal carcinomatosis for cytoreductive surgery and HIPEC on the condition that a CT examination will be performed using a dedicated protocol optimized to detect minimal peritoneal disease and CT images will be analyzed by an experienced reader.
Literature
1.
go back to reference Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108PubMedCrossRef
2.
go back to reference Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198–206PubMedCrossRef Meyers MA (1973) Distribution of intra-abdominal malignant seeding: dependency on dynamics of flow of ascitic fluid. Am J Roentgenol Radium Ther Nucl Med 119:198–206PubMedCrossRef
5.
go back to reference Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–228PubMedCrossRef Glehen O, Mohamed F, Gilly FN (2004) Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol 5:219–228PubMedCrossRef
6.
go back to reference Stewart JH 4th (2005) Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12:765–777PubMedCrossRef Stewart JH 4th (2005) Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12:765–777PubMedCrossRef
7.
go back to reference Roviello F, Caruso S, Marrelli D, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 20:38–54. doi:10.1016/j.suronc.2010.09.002 CrossRef Roviello F, Caruso S, Marrelli D, et al. (2011) Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments. Surg Oncol 20:38–54. doi:10.​1016/​j.​suronc.​2010.​09.​002 CrossRef
10.
go back to reference Roviello F, Pinto E, Corso G, et al. (2010) Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol 102:663–670. doi:10.1002/jso.21682 PubMedCrossRef Roviello F, Pinto E, Corso G, et al. (2010) Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer. J Surg Oncol 102:663–670. doi:10.​1002/​jso.​21682 PubMedCrossRef
11.
go back to reference Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374PubMedCrossRef Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374PubMedCrossRef
12.
go back to reference Pfannenberg C, Königsrainer I, Aschoff P, et al. (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int Ann Surg Oncol 16:1295–1303. doi:10.1245/s10434-009-0387-7 CrossRef Pfannenberg C, Königsrainer I, Aschoff P, et al. (2009) (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int Ann Surg Oncol 16:1295–1303. doi:10.​1245/​s10434-009-0387-7 CrossRef
13.
go back to reference Limei Z, Yong C, Yan X, et al. (2013) Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis. Int J Gynecol Cancer 23:598–607PubMedCrossRef Limei Z, Yong C, Yan X, et al. (2013) Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis. Int J Gynecol Cancer 23:598–607PubMedCrossRef
14.
go back to reference Klumpp BD, Aschoff P, Schwenzer N, et al. (2012) Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Imaging 37:834–842PubMedCrossRef Klumpp BD, Aschoff P, Schwenzer N, et al. (2012) Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings. Abdom Imaging 37:834–842PubMedCrossRef
17.
18.
go back to reference Roviello F, Marrelli D, Neri A, et al. (2006) Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg 30:2033–2040PubMedCrossRef Roviello F, Marrelli D, Neri A, et al. (2006) Treatment of peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion (IHCP): postoperative outcome and risk factors for morbidity. World J Surg 30:2033–2040PubMedCrossRef
20.
go back to reference Verwaal VJ, van Ruth S, de Bree E, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743PubMedCrossRef Verwaal VJ, van Ruth S, de Bree E, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743PubMedCrossRef
21.
go back to reference Bijelic L, Jonson A, Sugarbaker PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943–1950PubMedCrossRef Bijelic L, Jonson A, Sugarbaker PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943–1950PubMedCrossRef
22.
go back to reference Hamilton T, Lanuke K, Mack LA, Temple WJ (2011) Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg 201:650–654PubMedCrossRef Hamilton T, Lanuke K, Mack LA, Temple WJ (2011) Long-term follow-up in the treatment of peritoneal carcinomatosis. Am J Surg 201:650–654PubMedCrossRef
23.
go back to reference Sala E, Kataoka M, Pandit-Taskar N, et al. (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients’ survival. Radiology 257:125–134PubMedCrossRef Sala E, Kataoka M, Pandit-Taskar N, et al. (2010) Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients’ survival. Radiology 257:125–134PubMedCrossRef
24.
go back to reference Satoh Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447–453PubMedCrossRef Satoh Y, Ichikawa T, Motosugi U, et al. (2011) Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 196:447–453PubMedCrossRef
25.
go back to reference De Bree E, Koops W, Kroger R, et al. (2004) Peritoneal carcinomatosis from colorectal cancer or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73PubMedCrossRef De Bree E, Koops W, Kroger R, et al. (2004) Peritoneal carcinomatosis from colorectal cancer or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73PubMedCrossRef
26.
go back to reference Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499PubMedCrossRef Coakley FV, Choi PH, Gougoutas CA, et al. (2002) Peritoneal metastases: detection with spiral CT in patients with ovarian cancer. Radiology 223:495–499PubMedCrossRef
27.
go back to reference Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700. doi:10.1007/s00261-008-9464-9 PubMedCrossRef Marin D, Catalano C, Baski M, et al. (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35:694–700. doi:10.​1007/​s00261-008-9464-9 PubMedCrossRef
28.
go back to reference Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol 174:1005–1008CrossRef Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. Am J Roentgenol 174:1005–1008CrossRef
29.
go back to reference Mazzei MA, Cioffi Squitieri N, Sani E, et al. (2013) Differences in perfusion CT parameter values with commercial software upgrades: a preliminary report about algorithm consistency and stability. Acta Radiol. doi:10.1177/0284185113484643. Mazzei MA, Cioffi Squitieri N, Sani E, et al. (2013) Differences in perfusion CT parameter values with commercial software upgrades: a preliminary report about algorithm consistency and stability. Acta Radiol. doi:10.​1177/​0284185113484643​.
Metadata
Title
Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC)
Authors
Maria Antonietta Mazzei
Leila Khader
Alfredo Cirigliano
Nevada Cioffi Squitieri
Susanna Guerrini
Beatrice Forzoni
Daniele Marrelli
Franco Roviello
Francesco Giuseppe Mazzei
Luca Volterrani
Publication date
01-12-2013
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2013
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-013-0013-9

Other articles of this Issue 6/2013

Abdominal Radiology 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine